{"id":62177,"date":"2025-11-10T16:04:11","date_gmt":"2025-11-10T15:04:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/positive-development-applauds-aacaps-call-to-expand-autism-care-access-and-recommendation-that-payers-broaden-coverage-to-include-drbi\/"},"modified":"2025-11-10T16:04:11","modified_gmt":"2025-11-10T15:04:11","slug":"positive-development-applauds-aacaps-call-to-expand-autism-care-access-and-recommendation-that-payers-broaden-coverage-to-include-drbi","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/positive-development-applauds-aacaps-call-to-expand-autism-care-access-and-recommendation-that-payers-broaden-coverage-to-include-drbi\/","title":{"rendered":"Positive Development Applauds AACAP\u2019s Call to Expand Autism Care Access and Recommendation That Payers Broaden Coverage to Include DRBI"},"content":{"rendered":"
\n

\nNew AACAP policy statement not only recommends payers offer coverage for evidence-based developmental relationship-based therapies, but also advises all physicians consider DRBI when recommending treatment for autism<\/i><\/p>\n

MCLEAN, Va.–(BUSINESS WIRE)–#Autism<\/a>—The American Academy of Child and Adolescent Psychiatry<\/a> (AACAP) has published a new policy statement<\/a> recommending health insurers and physicians include a broader range of interventions, specifically Developmental Relationship-Based Interventions (DRBI), among recommended treatment options for all patients with autism. Positive Development<\/a>, the nation\u2019s leading provider of developmental therapy for autistic children and their families, celebrates this policy update and encourages payers to increase their autism care options to include DRBI as a covered choice for families.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cAACAP\u2019s policy statement signifies what we\u2019ve already recognized about the autism care market: there\u2019s tremendous momentum building behind developmental relationship-based therapy options,\u201d said Mike Suiters, Co-founder and CEO of Positive Development. \u201cNow the nation\u2019s leading physician organization and authority on children\u2019s mental health, in addition to the AMA and AAP, is calling for payers and physicians to support clinically validated developmental interventions that families are asking for, which are also designed to improve outcomes and reduce costs.\u201d<\/p>\n

\nAutism impacts 1 in 31 children<\/a> according to the CDC\u2019s latest prevalence study, yet access to services remains a challenge nationwide. AACAP\u2019s guidance reinforces the need for quality, alternative, evidence-based interventions that address the diversity of the autism spectrum.<\/p>\n

\nPositive Development President Chad Pomeroy added: \u201cI can\u2019t understate the importance of this national medical association\u2019s recognition of our lower intensity, lower utilization model as an effective autism care intervention, especially for Medicaid populations where affordability and accessibly are paramount.\u201d<\/p>\n

\nPositive Development supports aligning with AACAP\u2019s policy recommendations where payers can:<\/p>\n